Antibodies are highly specific, naturally evolved molecules that recognize and eliminate pathogens and tumour associated antigens. The organisation into distinct structural and functional domains facilitates their engineering. Driven by a variety of antibody engineering methods and technological developments, chimeric and humanized antibodies are commonly used as therapeutics for cancer, infectious and inflammatory diseases, for imaging or in targeted delivery systems. This chapter describes the cloning and expression of chimeric antibodies using Lonza’s “double-gene vectors” (Lonza Biologics’ Glutamine Synthetase (GS) gene expression system) in mammalian cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aarden L, Ruuls SR et al (2008) Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement. Curr Opin Immunol 20(4):431–435
Bebbington CR, Renner G et al (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology (N Y) 10(2):169–175
Jones PT, Dear PH et al (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321(6069):522–525
Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256(5517):495–497
Morrison SL, Johnson MJ et al (1984) Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 81(21):6851–6855
Shawler DL, Bartholomew RM et al (1985) Human immune response to multiple injections of murine monoclonal IgG. J Immunol 135(2):1530–1535
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag
About this protocol
Cite this protocol
Zettlitz, K.A. (2010). Generation of Heavy and Light Chains (Chimeric Antibodies). In: Kontermann, R., Dübel, S. (eds) Antibody Engineering. Springer Protocols Handbooks. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01144-3_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-01144-3_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01143-6
Online ISBN: 978-3-642-01144-3
eBook Packages: Springer Protocols